Biomerica Current Ratio vs Cost of Revenue Analysis
BMRA Stock | USD 0.76 0.01 1.33% |
Biomerica financial indicator trend analysis is way more than just evaluating Biomerica prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biomerica is a good investment. Please check the relationship between Biomerica Current Ratio and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.
Current Ratio vs Cost Of Revenue
Current Ratio vs Cost of Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biomerica Current Ratio account and Cost of Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Biomerica's Current Ratio and Cost of Revenue is -0.3. Overlapping area represents the amount of variation of Current Ratio that can explain the historical movement of Cost of Revenue in the same time period over historical financial statements of Biomerica, assuming nothing else is changed. The correlation between historical values of Biomerica's Current Ratio and Cost of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Ratio of Biomerica are associated (or correlated) with its Cost of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost of Revenue has no effect on the direction of Current Ratio i.e., Biomerica's Current Ratio and Cost of Revenue go up and down completely randomly.
Correlation Coefficient | -0.3 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Current Ratio
A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.Cost Of Revenue
Cost of Revenue is found on Biomerica income statement and represents the costs associated with goods and services Biomerica provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most indicators from Biomerica's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biomerica current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.The current year's Tax Provision is expected to grow to about 48 K, whereas Selling General Administrative is forecasted to decline to about 6.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 3.0M | 446K | 401.4K | 381.3K | Total Revenue | 18.9M | 5.3M | 6.1M | 7.6M |
Biomerica fundamental ratios Correlations
Click cells to compare fundamentals
Biomerica Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biomerica fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 17.3M | 11.8M | 11.4M | 14.5M | 16.6M | 17.5M | |
Other Current Liab | 278.6K | 540.7K | 883.3K | 1.2M | 1.1M | 1.2M | |
Total Current Liabilities | 1.5M | 1.3M | 2.0M | 1.9M | 1.8M | 1.3M | |
Total Stockholder Equity | 14.2M | 9.2M | 8.3M | 11.7M | 13.5M | 14.2M | |
Property Plant And Equipment Net | 2.0M | 1.9M | 1.5M | 1.2M | 1.4M | 1.5M | |
Net Debt | (6.9M) | (2.6M) | (4.5M) | (8.6M) | (7.8M) | (7.4M) | |
Retained Earnings | (21.9M) | (28.4M) | (35.1M) | (42.2M) | (38.0M) | (36.1M) | |
Cash | 8.6M | 4.2M | 5.9M | 9.7M | 11.2M | 11.7M | |
Non Current Assets Total | 2.5M | 2.6M | 1.9M | 1.7M | 1.9M | 1.3M | |
Non Currrent Assets Other | 168.2K | 264.2K | 95.6K | 79K | 71.1K | 67.5K | |
Cash And Short Term Investments | 8.6M | 4.2M | 5.9M | 9.7M | 11.2M | 11.7M | |
Net Receivables | 1.8M | 1.5M | 773.8K | 722K | 649.8K | 955.2K | |
Common Stock Shares Outstanding | 10.2M | 11.9M | 12.7M | 14.2M | 16.3M | 17.1M | |
Liabilities And Stockholders Equity | 17.3M | 11.8M | 11.4M | 14.5M | 16.6M | 17.5M | |
Non Current Liabilities Total | 1.6M | 1.3M | 1.0M | 785K | 902.8K | 857.6K | |
Inventory | 2.9M | 3.2M | 2.4M | 2.1M | 2.4M | 2.2M | |
Other Current Assets | 1.5M | 255.0 | 447.0 | 300K | 270K | 273.8K | |
Other Stockholder Equity | 35.2M | 36.7M | 42.4M | 52.7M | 60.6M | 63.6M | |
Total Liab | 3.0M | 2.6M | 3.0M | 2.7M | 2.5M | 1.4M | |
Property Plant And Equipment Gross | 2.0M | 1.9M | 3.5M | 3.2M | 3.7M | 3.9M | |
Total Current Assets | 14.8M | 9.2M | 9.4M | 12.8M | 14.7M | 15.5M | |
Accumulated Other Comprehensive Income | (39.8K) | (48.0K) | (73.9K) | (110K) | (126.5K) | (132.8K) | |
Accounts Payable | 986.7K | 431.6K | 736K | 344K | 309.6K | 575.0K | |
Intangible Assets | 168.7K | 294.8K | 170K | 165K | 148.5K | 276.5K | |
Common Stock Total Equity | 711.0K | 774.2K | 939.2K | 984.6K | 1.1M | 622.7K | |
Common Stock | 939.2K | 984.6K | 1.0M | 1.3M | 1.5M | 1.6M | |
Other Assets | 168.2K | 264.2K | 363.0 | 79K | 90.9K | 86.3K | |
Property Plant Equipment | 2.0M | 1.9M | 1.5M | 1.2M | 1.4M | 1.5M | |
Net Tangible Assets | 14.0M | 8.9M | 8.2M | 11.6M | 13.3M | 7.8M | |
Net Invested Capital | 14.2M | 9.2M | 8.3M | 11.7M | 13.5M | 8.8M | |
Net Working Capital | 13.3M | 7.9M | 7.4M | 10.9M | 12.5M | 7.9M | |
Capital Stock | 964.9K | 984.6K | 1.0M | 1.3M | 1.5M | 1.1M |
Pair Trading with Biomerica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomerica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomerica will appreciate offsetting losses from the drop in the long position's value.Moving against Biomerica Stock
0.41 | WST | West Pharmaceutical Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Biomerica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomerica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomerica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomerica to buy it.
The correlation of Biomerica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomerica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomerica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomerica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Biomerica Stock analysis
When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Biomerica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Revenue Per Share 0.323 | Quarterly Revenue Growth (0.09) | Return On Assets (0.43) | Return On Equity (0.92) |
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.